These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27178307)

  • 1. Serum and tissue profile of VEGF and its receptors VGFR1/R2 in children with infantile hemangiomas on systemic propranolol treatment.
    Przewratil P; Kobos J; Wnęk A; Szemraj J; Wyrzykowski D; Chrzanowska B; Andrzejewska E; Taran K
    Immunol Lett; 2016 Jul; 175():44-9. PubMed ID: 27178307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pigment epithelium-derived factor/vascular endothelial growth factor ratio plays a crucial role in the spontaneous regression of infant hemangioma and in the therapeutic effect of propranolol.
    Zhu L; Xie J; Liu Z; Huang Z; Huang M; Yin H; Qi W; Yang Z; Zhou T; Gao G; Zhang J; Yang X
    Cancer Sci; 2018 Jun; 109(6):1981-1994. PubMed ID: 29664206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propranolol induces regression of hemangioma cells via the down-regulation of the PI3K/Akt/eNOS/VEGF pathway.
    Pan WK; Li P; Guo ZT; Huang Q; Gao Y
    Pediatr Blood Cancer; 2015 Aug; 62(8):1414-20. PubMed ID: 25728347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum concentrations of VEGF and bFGF in the course of propranolol therapy of infantile hemangioma in children: Are we closer to understand the mechanism of action of propranolol on hemangiomas?
    Babiak-Choroszczak L; Giżewska-Kacprzak K; Gawrych E; Fischer K; Walecka A; Puchalska-Niedbał L; Rajewska-Majchrzak J; Bagłaj M
    Adv Clin Exp Med; 2018 May; 27(5):703-710. PubMed ID: 29790692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue and serum mRNA profile of MMPs-2/9 as a potential novel biomarker for the most individual approach in infantile hemangiomas and cancer disease.
    Taran K; Wnęk A; Kobos J; Andrzejewska E; Przewratil P
    Immunobiology; 2017 Nov; 222(11):1035-1042. PubMed ID: 28601470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum cytokine profiles in infants with infantile hemangiomas on oral propranolol treatment: VEGF and bFGF, potential biomarkers predicting clinical outcomes.
    Park M; Jung HL; Shim YJ; Kim HS; Yoon HS; Park SK; Cheuh HW; Lee MJ; Lee JM; Park ES; Lee JH; Lim YJ; Choi YB
    Pediatr Res; 2020 Nov; 88(5):749-755. PubMed ID: 32311699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum-level changes of vascular endothelial growth factor in children with infantile hemangioma after oral propranolol therapy.
    Chen XD; Ma G; Huang JL; Chen H; Jin YB; Ye XX; Hu XJ; Lin XX
    Pediatr Dermatol; 2013; 30(5):549-53. PubMed ID: 23909679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of vascular endothelial growth factor (VEGF) and its receptors VEGFR1 and VEGFR2 in primary and recurrent WHO grade III meningiomas.
    Baumgarten P; Brokinkel B; Zinke J; Zachskorn C; Ebel H; Albert FK; Stummer W; Plate KH; Harter PN; Hasselblatt M; Mittelbronn M
    Histol Histopathol; 2013 Sep; 28(9):1157-66. PubMed ID: 23475388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of VEGF and its receptors VEGFR1/VEGFR2 is associated with invasiveness of bladder cancer.
    Kopparapu PK; Boorjian SA; Robinson BD; Downes M; Gudas LJ; Mongan NP; Persson JL
    Anticancer Res; 2013 Jun; 33(6):2381-90. PubMed ID: 23749886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma.
    Jinnin M; Medici D; Park L; Limaye N; Liu Y; Boscolo E; Bischoff J; Vikkula M; Boye E; Olsen BR
    Nat Med; 2008 Nov; 14(11):1236-46. PubMed ID: 18931684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of VEGF and bFGF in infantile hemangiomas treated with propranolol.
    Şen HS; Yalçın B; Canpınar H; Ocak S; Akyüz C
    Turk J Pediatr; 2020; 62(6):979-985. PubMed ID: 33372436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and immunohistochemical expression of apoptotic proteins Bax, Bcl-2 and Caspase 3 in infantile hemangioma tissues as an effect of propranolol treatment.
    Wnęk A; Andrzejewska E; Kobos J; Taran K; Przewratil P
    Immunol Lett; 2017 May; 185():27-31. PubMed ID: 28279700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor response with propranolol therapy in patients with infantile hemangioma.
    Makkeyah SM; Elseedawy ME; Abdel-Kader HM; Mokhtar GM; Ragab IA
    Pediatr Hematol Oncol; 2022 Apr; 39(3):215-224. PubMed ID: 34477031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propranolol inhibits angiogenesis via down-regulating the expression of vascular endothelial growth factor in hemangioma derived stem cell.
    Zhang L; Mai HM; Zheng J; Zheng JW; Wang YA; Qin ZP; Li KL
    Int J Clin Exp Pathol; 2014; 7(1):48-55. PubMed ID: 24427325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propranolol for infantile hemangioma: Effect on plasma vascular endothelial growth factor.
    Ozeki M; Nozawa A; Hori T; Kanda K; Kimura T; Kawamoto N; Fukao T
    Pediatr Int; 2016 Nov; 58(11):1130-1135. PubMed ID: 26991797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of GLUT1, IGF-2, VEGF, FGF 1, and angiopoietin 2 in infantile hemangioma.
    Aydin Köker S; Kömüroğlu AU; Köksoy AY; Şiraz ÜG; Tekin E; Köker A
    Arch Pediatr; 2021 May; 28(4):296-300. PubMed ID: 33715934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propranolol induces regression of hemangioma cells through HIF-1α-mediated inhibition of VEGF-A.
    Chim H; Armijo BS; Miller E; Gliniak C; Serret MA; Gosain AK
    Ann Surg; 2012 Jul; 256(1):146-56. PubMed ID: 22580939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of vascular endothelial growth factor implies the limbal origin of pterygia.
    Gebhardt M; Mentlein R; Schaudig U; Pufe T; Recker K; Nölle B; Al-Samir K; Geerling G; Paulsen FP
    Ophthalmology; 2005 Jun; 112(6):1023-30. PubMed ID: 15885787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEGF receptor heterodimers and homodimers are differentially expressed in neuronal and endothelial cell types.
    Sarkar J; Luo Y; Zhou Q; Ivakhnitskaia E; Lara D; Katz E; Sun MG; Guaiquil V; Rosenblatt M
    PLoS One; 2022; 17(7):e0269818. PubMed ID: 35862373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of vascular endothelial growth factor A, its receptors VEGFR-1, -2, and -3 and co-receptors neuropilin-1 and -2 does not predict bevacizumab response in human astrocytomas.
    Baumgarten P; Blank AE; Franz K; Hattingen E; Dunst M; Zeiner P; Hoffmann K; Bähr O; Mäder L; Goeppert B; Machein M; Seifert V; Steinbach JP; Plate KH; Harter PN; Mittelbronn M
    Neuro Oncol; 2016 Feb; 18(2):173-83. PubMed ID: 26627848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.